Pericoronary Adipose Tissue Attenuation Is Associated with High-Risk Plaque and Subsequent Acute Coronary Syndrome in Patients with Stable Coronary Artery Disease

Background: High-risk plaques (HRP) detected on coronary computed tomography angiography (CTA) confer an increased risk of acute coronary syndrome (ACS). Pericoronary adipose tissue attenuation (PCAT) is a novel biomarker of coronary inflammation. This study aimed to evaluate the association of PCAT...

Full description

Bibliographic Details
Main Authors: Jeremy Yuvaraj, Andrew Lin, Nitesh Nerlekar, Ravi K. Munnur, James D. Cameron, Damini Dey, Stephen J. Nicholls, Dennis T. L. Wong
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/5/1143
_version_ 1797534786783281152
author Jeremy Yuvaraj
Andrew Lin
Nitesh Nerlekar
Ravi K. Munnur
James D. Cameron
Damini Dey
Stephen J. Nicholls
Dennis T. L. Wong
author_facet Jeremy Yuvaraj
Andrew Lin
Nitesh Nerlekar
Ravi K. Munnur
James D. Cameron
Damini Dey
Stephen J. Nicholls
Dennis T. L. Wong
author_sort Jeremy Yuvaraj
collection DOAJ
description Background: High-risk plaques (HRP) detected on coronary computed tomography angiography (CTA) confer an increased risk of acute coronary syndrome (ACS). Pericoronary adipose tissue attenuation (PCAT) is a novel biomarker of coronary inflammation. This study aimed to evaluate the association of PCAT with HRP and subsequent ACS development in patients with stable coronary artery disease (CAD). Methods: Patients with stable CAD who underwent coronary CTA from 2011 to 2016 and had available outcome data were included. We studied 41 patients with HRP propensity matched to 41 controls without HRP (60 ± 10 years, 67% males). PCAT was assessed using semi-automated software on a per-patient basis in the proximal right coronary artery (PCAT<sub>RCA</sub>) and a per-lesion basis (PCAT<sub>Lesion</sub>) around HRP in cases and the highest-grade stenosis lesions in controls. Results: PCAT<sub>RCA</sub> and PCAT<sub>Lesion</sub> were higher in HRP patients than controls (PCAT<sub>RCA</sub>: −80.7 ± 6.50 HU vs. −84.2 ± 8.09 HU, <i>p</i> = 0.03; PCAT<sub>Lesion</sub>: −79.6 ± 7.86 HU vs. −84.2 ± 10.3 HU, <i>p</i> = 0.04), and were also higher in men (PCAT<sub>RCA</sub>: −80.5 ± 7.03 HU vs. −86.1 ± 7.08 HU, <i>p</i> < 0.001; PCAT<sub>Lesion</sub>: −79.6 ± 9.06 HU vs. −85.2 ± 7.96 HU, <i>p</i> = 0.02). Median time to ACS was 1.9 years, within a median follow-up of 5.3 years. PCAT<sub>RCA</sub> alone was higher in HRP patients who subsequently presented with ACS (−76.8 ± 5.69 HU vs. −82.0 ± 6.32 HU, <i>p</i> = 0.03). In time-dependent analysis, ACS was associated with HRP and PCAT<sub>RCA</sub>. Conclusions: PCAT attenuation is increased in stable CAD patients with HRP and is associated with subsequent ACS development. Further investigation is required to determine the clinical implications of these findings.
first_indexed 2024-03-10T11:34:27Z
format Article
id doaj.art-3678a2577fee4191b5d11144a18d39bf
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T11:34:27Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-3678a2577fee4191b5d11144a18d39bf2023-11-21T18:56:21ZengMDPI AGCells2073-44092021-05-01105114310.3390/cells10051143Pericoronary Adipose Tissue Attenuation Is Associated with High-Risk Plaque and Subsequent Acute Coronary Syndrome in Patients with Stable Coronary Artery DiseaseJeremy Yuvaraj0Andrew Lin1Nitesh Nerlekar2Ravi K. Munnur3James D. Cameron4Damini Dey5Stephen J. Nicholls6Dennis T. L. Wong7Monash Cardiovascular Research Centre, Monash University and MonashHeart, Clayton, VIC 3800, AustraliaBiomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USAMonash Cardiovascular Research Centre, Monash University and MonashHeart, Clayton, VIC 3800, AustraliaMonash Cardiovascular Research Centre, Monash University and MonashHeart, Clayton, VIC 3800, AustraliaMonash Cardiovascular Research Centre, Monash University and MonashHeart, Clayton, VIC 3800, AustraliaBiomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USAMonash Cardiovascular Research Centre, Monash University and MonashHeart, Clayton, VIC 3800, AustraliaMonash Cardiovascular Research Centre, Monash University and MonashHeart, Clayton, VIC 3800, AustraliaBackground: High-risk plaques (HRP) detected on coronary computed tomography angiography (CTA) confer an increased risk of acute coronary syndrome (ACS). Pericoronary adipose tissue attenuation (PCAT) is a novel biomarker of coronary inflammation. This study aimed to evaluate the association of PCAT with HRP and subsequent ACS development in patients with stable coronary artery disease (CAD). Methods: Patients with stable CAD who underwent coronary CTA from 2011 to 2016 and had available outcome data were included. We studied 41 patients with HRP propensity matched to 41 controls without HRP (60 ± 10 years, 67% males). PCAT was assessed using semi-automated software on a per-patient basis in the proximal right coronary artery (PCAT<sub>RCA</sub>) and a per-lesion basis (PCAT<sub>Lesion</sub>) around HRP in cases and the highest-grade stenosis lesions in controls. Results: PCAT<sub>RCA</sub> and PCAT<sub>Lesion</sub> were higher in HRP patients than controls (PCAT<sub>RCA</sub>: −80.7 ± 6.50 HU vs. −84.2 ± 8.09 HU, <i>p</i> = 0.03; PCAT<sub>Lesion</sub>: −79.6 ± 7.86 HU vs. −84.2 ± 10.3 HU, <i>p</i> = 0.04), and were also higher in men (PCAT<sub>RCA</sub>: −80.5 ± 7.03 HU vs. −86.1 ± 7.08 HU, <i>p</i> < 0.001; PCAT<sub>Lesion</sub>: −79.6 ± 9.06 HU vs. −85.2 ± 7.96 HU, <i>p</i> = 0.02). Median time to ACS was 1.9 years, within a median follow-up of 5.3 years. PCAT<sub>RCA</sub> alone was higher in HRP patients who subsequently presented with ACS (−76.8 ± 5.69 HU vs. −82.0 ± 6.32 HU, <i>p</i> = 0.03). In time-dependent analysis, ACS was associated with HRP and PCAT<sub>RCA</sub>. Conclusions: PCAT attenuation is increased in stable CAD patients with HRP and is associated with subsequent ACS development. Further investigation is required to determine the clinical implications of these findings.https://www.mdpi.com/2073-4409/10/5/1143coronary computed tomography angiographyatherosclerosiscoronary artery diseasehigh-risk plaqueacute coronary syndromepericoronary adipose tissue
spellingShingle Jeremy Yuvaraj
Andrew Lin
Nitesh Nerlekar
Ravi K. Munnur
James D. Cameron
Damini Dey
Stephen J. Nicholls
Dennis T. L. Wong
Pericoronary Adipose Tissue Attenuation Is Associated with High-Risk Plaque and Subsequent Acute Coronary Syndrome in Patients with Stable Coronary Artery Disease
Cells
coronary computed tomography angiography
atherosclerosis
coronary artery disease
high-risk plaque
acute coronary syndrome
pericoronary adipose tissue
title Pericoronary Adipose Tissue Attenuation Is Associated with High-Risk Plaque and Subsequent Acute Coronary Syndrome in Patients with Stable Coronary Artery Disease
title_full Pericoronary Adipose Tissue Attenuation Is Associated with High-Risk Plaque and Subsequent Acute Coronary Syndrome in Patients with Stable Coronary Artery Disease
title_fullStr Pericoronary Adipose Tissue Attenuation Is Associated with High-Risk Plaque and Subsequent Acute Coronary Syndrome in Patients with Stable Coronary Artery Disease
title_full_unstemmed Pericoronary Adipose Tissue Attenuation Is Associated with High-Risk Plaque and Subsequent Acute Coronary Syndrome in Patients with Stable Coronary Artery Disease
title_short Pericoronary Adipose Tissue Attenuation Is Associated with High-Risk Plaque and Subsequent Acute Coronary Syndrome in Patients with Stable Coronary Artery Disease
title_sort pericoronary adipose tissue attenuation is associated with high risk plaque and subsequent acute coronary syndrome in patients with stable coronary artery disease
topic coronary computed tomography angiography
atherosclerosis
coronary artery disease
high-risk plaque
acute coronary syndrome
pericoronary adipose tissue
url https://www.mdpi.com/2073-4409/10/5/1143
work_keys_str_mv AT jeremyyuvaraj pericoronaryadiposetissueattenuationisassociatedwithhighriskplaqueandsubsequentacutecoronarysyndromeinpatientswithstablecoronaryarterydisease
AT andrewlin pericoronaryadiposetissueattenuationisassociatedwithhighriskplaqueandsubsequentacutecoronarysyndromeinpatientswithstablecoronaryarterydisease
AT niteshnerlekar pericoronaryadiposetissueattenuationisassociatedwithhighriskplaqueandsubsequentacutecoronarysyndromeinpatientswithstablecoronaryarterydisease
AT ravikmunnur pericoronaryadiposetissueattenuationisassociatedwithhighriskplaqueandsubsequentacutecoronarysyndromeinpatientswithstablecoronaryarterydisease
AT jamesdcameron pericoronaryadiposetissueattenuationisassociatedwithhighriskplaqueandsubsequentacutecoronarysyndromeinpatientswithstablecoronaryarterydisease
AT daminidey pericoronaryadiposetissueattenuationisassociatedwithhighriskplaqueandsubsequentacutecoronarysyndromeinpatientswithstablecoronaryarterydisease
AT stephenjnicholls pericoronaryadiposetissueattenuationisassociatedwithhighriskplaqueandsubsequentacutecoronarysyndromeinpatientswithstablecoronaryarterydisease
AT dennistlwong pericoronaryadiposetissueattenuationisassociatedwithhighriskplaqueandsubsequentacutecoronarysyndromeinpatientswithstablecoronaryarterydisease